|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,653.45 INR | +1.68% |
|
+5.58% | +7.39% |
| Market Cap | 450B 4.71B 4.09B 3.81B 3.5B 6.61B 6.71B 44.91B 17.63B 224B 17.68B 17.3B 750B | P/E 2027 * |
39.1x | P/E 2028 * | 34.7x |
|---|---|---|---|---|---|
| Enterprise Value | 450B 4.71B 4.09B 3.81B 3.5B 6.61B 6.71B 44.91B 17.63B 224B 17.68B 17.3B 750B | EV / Sales 2027 * |
10.7x | EV / Sales 2028 * | 9.67x |
| Free-Float |
24.37% | Yield 2027 * |
1.11% | Yield 2028 * | 1.11% |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | +1.68% | ||
| 1 week | +5.58% | ||
| 1 month | +8.26% | ||
| 3 months | +13.61% | ||
| 6 months | +10.68% | ||
| Current year | +7.39% |
| 1 week | 2,494.7 | 2,675.1 | |
| 1 month | 2,370.65 | 2,675.1 | |
| Current year | 2,088 | 2,715.15 | |
| 1 year | 2,088 | 2,935.85 | |
| 3 years | 1,387.9 | 3,515.95 | |
| 5 years | 1,228 | 3,515.95 | |
| 10 years | 1,020 | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 30/11/2022 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 31/03/2026 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 07/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Subesh Williams
BRD | Director/Board Member | 64 | 06/04/2017 |
Renu Sud Karnad
CHM | Chairman | 73 | 31/03/2019 |
| Director/Board Member | 59 | 17/05/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.68% | +5.58% | -15.98% | +89.80% | 4.71B | ||
| -0.53% | -3.95% | +55.23% | +152.74% | 1,024B | ||
| +0.21% | -2.68% | +55.61% | +53.02% | 618B | ||
| -2.51% | -3.25% | +32.76% | +67.76% | 443B | ||
| +0.06% | -0.42% | +37.53% | +30.67% | 349B | ||
| -0.14% | -0.24% | +34.41% | +39.01% | 297B | ||
| -0.69% | -0.30% | +11.55% | +12.93% | 264B | ||
| -7.37% | -4.40% | -2.54% | -43.87% | 209B | ||
| -0.64% | +2.43% | +30.52% | +64.49% | 208B | ||
| -0.82% | +0.70% | +15.96% | +71.01% | 162B | ||
| Average | -1.08% | -0.52% | +25.50% | +53.76% | 357.85B | |
| Weighted average by Cap. | -0.98% | -1.92% | +39.17% | +72.98% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 41.99B 440M 382M 356M 327M 617M 627M 4.2B 1.65B 20.9B 1.65B 1.62B 70.09B | 46.49B 487M 423M 394M 362M 683M 694M 4.64B 1.82B 23.14B 1.83B 1.79B 77.61B |
| Net income | 11.42B 120M 104M 96.77M 88.85M 168M 170M 1.14B 448M 5.68B 449M 439M 19.06B | 12.54B 131M 114M 106M 97.61M 184M 187M 1.25B 492M 6.24B 493M 483M 20.94B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | ₹2,653.45 | +1.68% | 2,858 |
| 30/07/26 | ₹2,609.65 | -0.67% | 2,303 |
| 29/07/26 | ₹2,627.35 | -0.52% | 6,448 |
| 28/07/26 | ₹2,641.20 | +3.57% | 4,963 |
| 27/07/26 | ₹2,550.20 | +1.47% | 2,697 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions

















